60 March 2016 NJMONTHLY.COM
Special Advertising Section
Q: What are the negative consequences of subglandular
A: Revision rates are quite high and require far more elabo-
rate surgery to correct problems.
RUTGERS CANCER INSTITUTE
OF NEW JERSEY
Dr. Deborah L. Toppmeyer, director, Stacy Goldstein
Q: When is the
appropriate time for
women to receive
A: The new
Society guidelines recommend that women
from ages 45 to 54
should continue with
an annual screening mammography,
and then do it every
other year from age
55 on. Women under
45 should consult
with their doctor based on personal risk and family history.
Nonetheless, most organizations are still endorsing annual
mammography beginning at age 40, with variable recommendations regarding when to discontinue screening.
Q: What technology is used during breast cancer
A: Typically 2-D mammography, which shows the breast
in two dimensions, is used for screening. The newer 3-D
mammography, or tomosynthesis, is more sensitive, increasing breast cancer detection rates while decreasing the number
of callbacks for abnormalities seen on screening. The 3-D
technology is becoming more available but is not usually
covered by most insurers at this time. Although detection rate
is improved, we do not know if this technology will lead to
improved overall survival.
Q: What services are offered at the Stacy Goldstein
Breast Cancer Center?
A: We take a multidisciplinary approach to breast cancer
Q: Can obesity impact a woman’s chances of getting
care and offer access to cutting-edge clinical trials. Our coor-
dinated care team works collaboratively on genetic counsel-
ing, risk assessment, and surgical, medical and radiation treat-
A: Being overweight has been associated with an increased
risk of numerous cancers, including breast, colon and endometrial cancer. In fact, if all adults reduced their body mass
index (BMI) by 1 percent, that would result in the avoidance
of approximately 100,000 new cases of cancer.
MONTCLAIR BREAST CENTER
Dr. Stacey Vitiello, breast imaging and biopsy specialist
Q: How valuable is breast MRI for the screening of
A: Breast MRI is hands down the best test that exists to
date for the detection of breast cancer. Unfortunately it can’t
be offered to all women because of various factors, including
cost, the time it takes and the lack of qualified people to read
the scans. But someday in the future it may potentially replace
mammography as a much more sensitive screen test for breast
Q: How much more sensitive is a breast MRI than a
A: For a woman with extremely dense breast tissue, a
mammogram finds about half of the cancers that can actually
be addressed. In that situation, we offer those women a second-level screening test—usually a breast ultrasound. But for
high-risk women, the second-level test is a breast MRI. The
combination of mammography and ultrasound gives us about
an 80 to 85 percent sensitivity, depending on who is doing
Deborah Toppmeyer, MD.
From left: Gail Quackenbush, MD; Marcie Hertz, MD, FACS;
Stacey Vitiello, MD; Nancy Elliott, MD, FACS; Melissa Lee, MD.